tiprankstipranks
Trending News
More News >
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
US Market
Advertisement

Relmada Therapeutics (RLMD) Technical Analysis

Compare
378 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
5Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Relmada Therapeutics’s (RLMD) Moving Averages Convergence Divergence (MACD) indicator is 0.26, suggesting Relmada Therapeutics is a Buy.
Relmada Therapeutics’s (RLMD) 20-Day exponential moving average is 1.89, while Relmada Therapeutics’s (RLMD) share price is $2.2, making it a Buy.
Relmada Therapeutics’s (RLMD) 50-Day exponential moving average is 1.46, while Relmada Therapeutics’s (RLMD) share price is $2.2, making it a Buy.

Relmada Therapeutics (RLMD) Pivot Points

Oct 10, 2025, 01:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.83
1.90
2.01
2.08
2.19
2.26
2.37
Fibonacci
1.90
1.97
2.01
2.08
2.15
2.19
2.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relmada Therapeutics (RLMD) Moving Averages

Oct 10, 2025, 01:08 PM
Period
Simple
Exponential
MA5
2.14Buy
2.15Buy
MA10
2.12Buy
2.08Buy
MA20
1.87Buy
1.89Buy
MA50
1.28Buy
1.46Buy
MA100
0.97Buy
1.16Buy
MA200
0.66Buy
1.13Buy
Relmada Therapeutics’s (RLMD) 10-Day exponential moving average is 2.08, while Relmada Therapeutics’s (RLMD) share price is $2.2, making it a Buy.
Relmada Therapeutics’s (RLMD) 100-Day exponential moving average is 1.16, while Relmada Therapeutics’s (RLMD) share price is $2.2, making it a Buy.
Relmada Therapeutics’s (RLMD) stock price is $2.2 and Relmada Therapeutics’s (RLMD) 50-day simple moving average is 1.28, creating a Buy signal.
Relmada Therapeutics’s (RLMD) stock price is $2.2 and Relmada Therapeutics’s (RLMD) 100-day simple moving average is 0.97, creating a Buy signal.
Relmada Therapeutics’s (RLMD) stock price is $2.2 and Relmada Therapeutics’s (RLMD) 200-day simple moving average is 0.66, creating a Buy signal.

Relmada Therapeutics (RLMD) Technical Indicators

Oct 10, 2025, 01:08 PM
Name
Value
Implied Action
RSI (14)
62.70
Neutral
STOCH (9,6)
38.93
Neutral
STOCHRSI (14)
46.47
Neutral
MACD (12,26)
0.26
Buy
ADX (14)
61.18
Sell
Williams %R
-46.72
Buy
CCI (14)
79.73
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
54.92
Neutral
ROC
43.79
Buy
Relmada Therapeutics’s (RLMD) Relative Strength Index (RSI) is 62.70, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Trend Strength Indicator (ADX) is 61.18, creating a Sell signal.
Relmada Therapeutics’s (RLMD) Commodity Channel Index (CCI) is 79.73, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Price Rate of Change (ROC) is 43.79, creating a Buy signal.

FAQ

Is RLMD a Buy, Hold, or Sell?
Based on RLMD’s technical indicators, RLMD is a Strong Buy.
    What is RLMD’s RSI (14)?
    RLMD’s RSI (14) is 62.70, which suggests RLMD is a Neutral.
      What is RLMD’s MACD?
      RLMD’s MACD is 0.26, which suggests RLMD is a Buy.
        What is RLMD’s 5-day moving average?
        RLMD’s 5-day moving average is 2.14, which suggests RLMD is a Buy.
          What is RLMD’s 20-day moving average?
          RLMD 20-day moving average is 1.87, which suggests RLMD is a Buy.
            What is RLMD’s 50-day moving average?
            RLMD’s 50-day moving average is 1.28, which suggests RLMD is a Buy.
              What is RLMD’s 200-day moving average?
              RLMD’s 200-day moving average is 0.66, which suggests RLMD is a Buy.
                What is RLMD’s Williams % R (14)?
                RLMD’s Williams % R (14) is -46.72, which suggests RLMD is a Buy.
                  What is RLMD’s CCI (14)?
                  RLMD’s CCI (14) is 79.73, which suggests RLMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis